MS
FMTX

Maven Securities’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Maven Securities’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-386,300
Closed -$7.71M – 1206
2022
Q3 		$7.71M Buy
+386,300
New +$5.09M 0.14% 77

Maven Securities's FMTX Position: Q4 2022 in Review

Maven Securities sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 200,000 shares — an estimated $3.99M sold.

Maven Securities first reported a position in FMTX in Q4 2020 and held it in 3 quarters. The position peaked at $3.99M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Maven Securities reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Maven Securities sold 200,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $3.99M.
  • Maven Securities first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Maven Securities's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $3.99M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Maven Securities's 13F filing for Q4 2022, filed 14 Feb 2023.